These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Multisite analytic performance studies of a real-time polymerase chain reaction assay for the detection of BRAF V600E mutations in formalin-fixed, paraffin-embedded tissue specimens of malignant melanoma. Anderson S, Bloom KJ, Vallera DU, Rueschoff J, Meldrum C, Schilling R, Kovach B, Lee JR, Ochoa P, Langland R, Halait H, Lawrence HJ, Dugan MC. Arch Pathol Lab Med; 2012 Nov; 136(11):1385-91. PubMed ID: 22332713 [Abstract] [Full Text] [Related]
3. Detection of BRAF p.V600E Mutations in Melanoma by Immunohistochemistry Has a Good Interobserver Reproducibility. Marin C, Beauchet A, Capper D, Zimmermann U, Julié C, Ilie M, Saiag P, von Deimling A, Hofman P, Emile JF. Arch Pathol Lab Med; 2014 Jan; 138(1):71-5. PubMed ID: 23651150 [Abstract] [Full Text] [Related]
6. Analytical performance of a real-time PCR-based assay for V600 mutations in the BRAF gene, used as the companion diagnostic test for the novel BRAF inhibitor vemurafenib in metastatic melanoma. Halait H, Demartin K, Shah S, Soviero S, Langland R, Cheng S, Hillman G, Wu L, Lawrence HJ. Diagn Mol Pathol; 2012 Mar; 21(1):1-8. PubMed ID: 22306669 [Abstract] [Full Text] [Related]
8. Spectrum and Frequency of BRAF Mutations in Skin Melanomas in the Dalmatian Region of Croatia. Bezić J, Tomić I, Pavić M. Acta Dermatovenerol Croat; 2024 Mar; 32(1):75-76. PubMed ID: 38946192 [Abstract] [Full Text] [Related]
11. [Utility and evaluation of immunohistochemical detection of BRAF V600E mutation in melanoma]. Lyu JJ, Kong YY, Cai X, Shen XX, Lu YW, Ren M. Zhonghua Bing Li Xue Za Zhi; 2017 Aug 08; 46(8):548-552. PubMed ID: 28810295 [Abstract] [Full Text] [Related]
12. Immunohistochemical analysis of BRAF(V600E) expression of primary and metastatic melanoma and comparison with mutation status and melanocyte differentiation antigens of metastatic lesions. Busam KJ, Hedvat C, Pulitzer M, von Deimling A, Jungbluth AA. Am J Surg Pathol; 2013 Mar 08; 37(3):413-20. PubMed ID: 23211290 [Abstract] [Full Text] [Related]
15. Rapid BRAF mutation tests in patients with advanced melanoma: comparison of immunohistochemistry, Droplet Digital PCR, and the Idylla Mutation Platform. Bisschop C, Ter Elst A, Bosman LJ, Platteel I, Jalving M, van den Berg A, Diepstra A, van Hemel B, Diercks GFH, Hospers GAP, Schuuring E. Melanoma Res; 2018 Apr 08; 28(2):96-104. PubMed ID: 29232304 [Abstract] [Full Text] [Related]
16. Validation of the VE1 immunostain for the BRAF V600E mutation in melanoma. Pearlstein MV, Zedek DC, Ollila DW, Treece A, Gulley ML, Groben PA, Thomas NE. J Cutan Pathol; 2014 Sep 08; 41(9):724-32. PubMed ID: 24917033 [Abstract] [Full Text] [Related]
18. BRAFV600E mutation analysis by immunohistochemistry in patients with thoracic metastases from colorectal cancer. Ilie MI, Long-Mira E, Hofman V, Mouroux J, Vignaud JM, Gauchotte G, Begueret H, Merlio JP, Emile JF, Hébuterne X, Hofman P. Pathology; 2014 Jun 08; 46(4):311-5. PubMed ID: 24798160 [Abstract] [Full Text] [Related]
19. Detection of BRAF V600 mutations in metastatic melanoma: comparison of the Cobas 4800 and Sanger sequencing assays. Qu K, Pan Q, Zhang X, Rodriguez L, Zhang K, Li H, Ho A, Sanders H, Sferruzza A, Cheng SM, Nguyen D, Jones D, Waldman F. J Mol Diagn; 2013 Nov 08; 15(6):790-5. PubMed ID: 23994118 [Abstract] [Full Text] [Related]